Literature DB >> 22349537

[Rheumatic patients in the intensive care unit].

P Lehmann1, T Brünnler, B Salzberger, M Fleck.   

Abstract

The mortality of patients with rheumatic diseases in the intensive care unit is generally high despite their relatively young age. In these patients, it is often difficult to make the diagnosis of the underlying autoimmune disease or to differentiate between septic complications and an acute flare; likewise, the complexity of the specific antirheumatic therapy can also be accompanied by problems. The following article gives an overview of problems in the diagnosis and treatment of critically ill patients with autoimmune diseases in the intensive care unit.

Entities:  

Mesh:

Year:  2012        PMID: 22349537     DOI: 10.1007/s00063-011-0073-y

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  29 in total

1.  Outcome of patients with systemic rheumatic diseases admitted to a medical intensive care unit.

Authors:  Javier A Cavallasca; María Del Rosario Maliandi; Sergio Sarquis; Maria Betina Nishishinya; Alejandra Schvartz; Abelardo Capdevila; Gustavo G Nasswetter
Journal:  J Clin Rheumatol       Date:  2010-12       Impact factor: 3.517

2.  Removing antibody and preserving glomeruli in ANCA small-vessel vasculitis.

Authors:  Sofia Lionaki; Ronald J Falk
Journal:  J Am Soc Nephrol       Date:  2007-07       Impact factor: 10.121

3.  An audit of patients with rheumatic disease requiring medical intensive care.

Authors:  B Y Thong; D Y Tai; S K Goh; A Johan
Journal:  Ann Acad Med Singap       Date:  2001-05       Impact factor: 2.473

4.  Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome.

Authors:  F M K Williams; S Chinn; G R V Hughes; R M Leach
Journal:  Ann Rheum Dis       Date:  2002-05       Impact factor: 19.103

5.  Prognosis of patients with systemic rheumatic diseases admitted to the intensive care unit.

Authors:  Mickaël Moreels; Christian Mélot; Marc Leeman
Journal:  Intensive Care Med       Date:  2005-01-28       Impact factor: 17.440

6.  Survival of patients with SLE admitted to an intensive care unit-a retrospective study.

Authors:  D A Whitelaw; R Gopal; V Freeman
Journal:  Clin Rheumatol       Date:  2004-11-25       Impact factor: 2.980

7.  Outcome of patients having dermatomyositis admitted to the intensive care unit.

Authors:  Yaniv Sherer; Daniel Shepshelovich; Tamara Shalev; Yael Haviv; Eran Segal; Michael Ehrenfeld; Yair Levy; Rachel Pauzner; Yehuda Shoenfeld; Pnina Langevitz
Journal:  Clin Rheumatol       Date:  2007-02-27       Impact factor: 2.980

8.  Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.

Authors:  W G Dixon; K Watson; M Lunt; K L Hyrich; A J Silman; D P M Symmons
Journal:  Arthritis Rheum       Date:  2006-08

9.  Outcome of patients with systemic lupus erythematosus in intensive care unit.

Authors:  A H Alzeer; A Al-Arfaj; S J Basha; S Alballa; J Al-Wakeel; H Al-Arfaj; S Al-Sugair; S Al-Mugeiren; M Al-Shamairi; E A Bamgboye
Journal:  Lupus       Date:  2004       Impact factor: 2.911

10.  Prognostic factors in patients with systemic lupus erythematosus admitted to the intensive care unit.

Authors:  S A Namendys-Silva; J A Baltazar-Torres; E Rivero-Sigarroa; J A Fonseca-Lazcano; L Montiel-López; G Domínguez-Cherit
Journal:  Lupus       Date:  2009-10-22       Impact factor: 2.911

View more
  2 in total

1.  [Acute dyspnea, subfebrile temperatures and chills in a patient with multiple myeloma].

Authors:  M Merz; I Herth; J Brandt; M Hundemer; K Neben; H Goldschmidt; C P Heußel
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-10-23       Impact factor: 0.840

2.  Comparative analysis of high CRP-levels in human blood using point-of-care and laboratory-based methods.

Authors:  Christiane Eckschlager; Karin Schwenoha; Caroline Roth; Barbara Bogner; Gertie Janneke Oostingh
Journal:  Pract Lab Med       Date:  2019-09-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.